| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8be6a6c990669567cc455d32b00535e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6897 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-10 |
| filingDate |
1995-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b6f9f738fd286fcedc613dab0bfde95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c22059ce707814d547320cfee26db5d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ea9e3f68922795250d0d1fe4a8494af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff88dc1d20f5670d18ee7c4865875389
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_110be1ed362c383aa41cd52fba476cf5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_667bee412391fc346c6bf08b8a2f0875 |
| publicationDate |
1998-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5807534-A |
| titleOfInvention |
In vivo binding pair pretargeting |
| abstract |
A method for in-vivo targeting a functional moiety in a patient by administering a targeting moiety coupled to an affinity component, wherein the targeting moiety has affinity for binding sites in a target area, and administering a binding partner to the affinity component coupled to a functional moiety to localize the functional moiety in the target area. Preferably the targeting moiety is an antibody and the functional moiety is a radiometal when performing in vivo imaging or therapy. The affinity component may be a novel methotrexate analog. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009101875-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009104113-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009104179-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009101838-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009101841-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009101846-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8684898-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003198633-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8227204-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102008052357-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007009427-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007009428-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9557635-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8168958-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8164074-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8529426-B2 |
| priorityDate |
1992-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |